Literature DB >> 31876471

Why Include the Public in Genome Editing Governance Deliberation?

Alessandro Blasimme1.   

Abstract

With the birth of genetically engineered twins in November 2018, international debate about human genome editing governance has moved from an emphasis on mutual engagement among multiple stakeholders to a self-regulatory model enacted through high-level expert groups with little or no public input. This article reconstructs this paradigm shift and suggests that inclusive public deliberation should still have a role in public decision making about genome editing.
© 2019 American Medical Association. All Rights Reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31876471     DOI: 10.1001/amajethics.2019.1065

Source DB:  PubMed          Journal:  AMA J Ethics


  2 in total

1.  The View from the Benches: Scientists' Perspectives on the Uses and Governance of Human Gene-Editing Research.

Authors:  Margaret Waltz; Eric T Juengst; Teresa Edwards; Gail E Henderson; Kristine J Kuczynski; John M Conley; Paige Della-Penna; R Jean Cadigan
Journal:  CRISPR J       Date:  2021-08

2.  Human genome editing: how to prevent rogue actors.

Authors:  Beverley A Townsend
Journal:  BMC Med Ethics       Date:  2020-10-06       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.